Malegra FXT is a combined pharmaceutical formulation designed to address specific male sexual health concerns. The medication contains two active components that work together to modulate erectile function and ejaculatory control. The first component enhances blood flow to the penile tissue, supporting the physiological processes needed for an erection. The second component influences pathways that regulate the timing of ejaculation, helping to prolong sexual activity. Together these actions improve the overall sexual response in men experiencing certain physiological challenges. Pharmacologically the agents act on specific receptors that are involved in smooth muscle relaxation and neural signaling. By targeting these receptors the drug reduces the threshold for achieving a firm erection and delays premature autonomic responses. The combined effect provides a therapeutic option that addresses both vascular and nervous system aspects of male sexual dysfunction.

Malegra FXT is a fixed-dose combination tablet used in the treatment of erectile dysfunction and premature ejaculation. The formulation contains sildenafil citrate which acts as a phosphodiesterase type-5 inhibitor promoting vasodilation in penile tissue. It also includes dapoxetine a selective serotonin reuptake inhibitor that delays ejaculation by modulating serotonin activity in the central nervous system. Sildenafil enhances nitric oxide mediated signaling leading to increased cyclic guanosine monophosphate and relaxation of smooth muscle. This relaxation improves blood flow enabling a firm erection when sexual stimulation occurs. Dapoxetine inhibits the serotonin transporter reducing the neuronal reuptake of serotonin and prolonging its effect on ejaculatory pathways. The combined action addresses both vascular insufficiency and neuro-chemical control to improve sexual performance. The drug is administered orally and provides a transient therapeutic effect lasting several hours.

Malegra FXT can cause mild headache. Some users report occasional dizziness. Nausea may occur intermittently. Back pain or muscle aches have been noted. Rarely visual disturbances such as blurred vision appear. A temporary increase in heart rate is possible. These effects are generally mild and short lived. Monitoring personal response helps assess any changes.

Malegra FXT may cause mild gastrointestinal discomfort in some users. Headache is among the commonly reported adverse reactions during clinical studies. Dizziness can occasionally occur, especially when standing up quickly. Some individuals may experience facial flushing or warmth in the neck area. Nausea and mild visual disturbances such as blurred vision have been documented. Less frequent effects include muscle aches or back pain that usually resolve without intervention.